Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia.
暂无分享,去创建一个
[1] J. Watari,et al. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] J. Watari,et al. Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma , 2003, Gut.
[3] J. Peters,et al. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus , 2002, American Journal of Gastroenterology.
[4] R. Goyal,et al. Phenotype of Barrett's Esophagus and Intestinal Metaplasia of the Distal Esophagus and Gastroesophageal Junction: An Immunohistochemical Study of Cytokeratins 7 and 20, Das-1 and 45MI , 2001, The American journal of surgical pathology.
[5] B. Diamond,et al. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. , 1987, Journal of immunology.
[6] A. Salas,et al. Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia. , 2009, American journal of clinical pathology.
[7] M. Piazuelo,et al. Phenotypic differences between esophageal and gastric intestinal metaplasia , 2004, Modern Pathology.